AzTrials
AzTrials

Knee OsteoarthritisNCT04418687

Use of the Orthoglide for Improved Patient Outcome Following Total Knee Replacement

A study testing Orthoglide and Physiotherapy only in people with Knee Osteoarthritis and Physiotherapy, run by Ambreen Chohan at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Total knee replacements are a common orthopaedic procedure undertaken at Blackpool Victoria Hospital. Following surgery patients are routinely seen by Physiotherapists who prescribe exercises to improve the range of movement and strength of the knee joint, thus aiding recovery. Read more about this study

Who is it for?
Ages 45 to 75 years
Conditions the study is for
Knee Osteoarthritis, Physiotherapy, Intervention
What is being tested?
Orthoglide and Physiotherapy only
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteUnited Kingdom
Study dates
28 Nov 2018to 31 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients planned to undergo a unilateral total knee replacement at Blackpool Victoria Hospital aged between 45 to 75 years,
  • Independently mobile with or without a walking aid.

Who cannot join

  • Other lower limb orthopaedic surgery within the last six-months,
  • No anticipated further lower limb orthopaedic surgery within the next 12-months,
  • No rheumatoid arthritis, neurological conditions affecting lower limb function.
  • No Cognitive impairment,
  • No co-morbidity which would act as a contraindication to engaging with prescribed exercise
  • No existing participation in other clinical trials which may impact rehabilitation outcomes.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Blackpool Victoria Hospital

    Blackpool, Lancashire, FY3 8NR

Other trials in United Kingdom

About this study

Official title: Does the Use of an Orthoglide Device Improve Patient Outcome, Following Total Knee Replacement

Total knee replacements are a common orthopaedic procedure undertaken at Blackpool Victoria Hospital. Following surgery patients are routinely seen by Physiotherapists who prescribe exercises to improve the range of movement and strength of the knee joint, thus aiding recovery. One of the key exercises prescribed involves the bending and straightening of the knee to improve range of movement. At this early stage of rehabilitation , due to weakness in the knee joint, reducing any resistance to this motion is beneficial. The Orthoglide device is designed to aid the patient in performing this movement by reducing the friction/resistance caused by the heel sliding against the bed. Currently this is achieved using a 'slider board' and placing a rolled up piece of fabric under the patients heel. The aim of this study is to investigate whether or not issuing an Orthoglide device to patients following total knee replacements improves functional outcomes reported by the patient at 6 weeks and 12 weeks post-surgery. Participants will be assigned to either receive an Orthoglide device and standard Physiotherapy or standard Physiotherapy alone. A series of patient reported outcome measures will be taken pre-surgery, 6 weeks post surgery and 12 weeks post surgery and the results compared.

Read the detailed description

It is hypothesised that issuing an Orthoglide device following total knee replacement will improve patient reported outcomes. The null-hypothesis is that there is no correlation between the issuing of an Orthoglide device and improved patient reported outcome measures post total knee replacement.

The following outlines the various stages which the research participants will pass through during the study:

  1. Initial contact - having been identified as requiring a total knee replacement the patient will attend Blackpool Victoria Hospital for a routine pre-operative assessment. During this contact the patient will be given an information pack relating to the project, this patient information sheet will include an invitation to participate, information regarding confidentiality, contact information as well as a consent form to be taken away and considered at home.
  2. Homeward visit - The Homeward team routinely complete home visits with all patients who are awaiting a total knee replacement. During this visit the clinician will further discuss the study and, if the patient wishes to take part, the consent forms may be collected. The visiting clinician will store these sealed envelopes in-line with trust policy on data protection - in a lockable drawer/cabinet upon return to the hospital, this will only be accessible by the Homeward Team and research team.
  3. Establishing baseline measurements - Consent forms will be reviewed by Robyn Jones and a copy placed in the patients records. Contact details will be recorded on secure access computer folder and participants contacted on preferred telephone number to establish baseline scores of outcome measures, gaining verbal consent prior to commencing. Consent forms will be stored in patients notes via coding with a further copy remaining in a secured storage location only accessible by the research team, for our records. Outcome measure scores will be inputted onto an anonymised and encrypted spreadsheet which will be stored on a password protected computer folder.
  4. Randomisation - Due to the time period the trial will take place over the investigators will employ block randomisation to allow the participants to be grouped in a timely manner prior to their surgery. Once the participants identity has been anonymised and encrypted participants will be randomised in groups of 10, i.e. every 10 patients recruited will be randomised as one block. This process will repeat for every group of 10 recruited until capacity is reached for the intervention group and the control group. As a feasibility study it is estimated that 30 participants in each arm will be sufficient to give adequate power.
  5. Identification of participants on weekly operation list - The Orthopaedic Physiotherapy team routinely access operation lists to identify the appropriate patients for Physiotherapy input. These operation lists will be cross referenced with our participant list to identify those taking part in the study and which group participants have been randomised into.
  6. Patients will attend Blackpool Victoria Hospital for surgery. Routine post-operative Physiotherapy rehabilitation protocols will be followed with the only variation being the issue of an Orthoglide device to those in the study group and not to those in the control group - as identified in stage 5. Patients generally remain an in-patient for approximately 3 days post surgery.
  7. 6 week follow up call - 6 weeks after the date of surgery (recorded in the secured spreadsheet from the weekly operation list)the research team will contact the patient to complete the outcome measures as used in stage 3, this data will be inputted onto the anonymised and encrypted spreadsheet stored on a password protected computer.
  8. 12 week follow up call - 12 weeks after the date of surgery the research team will contact the patient to complete the outcome measures as used in stage 3 and 7, this data will be inputted onto the anonymised and encrypted spreadsheet stored on a password protected computer.
  9. Data analysis and write up - Once all data is collected it will be analysed using the appropriate statistical analysis method and software. This study is designed to cause as little disruption to the routine patient journey as possible. Outside of routine contacts made by the direct care team, the only additional commitments participants must make is to be contacted by telephone by the research team 3 times (pre-operative baseline, 6 week follow-up and 12 week follow-up), each lasting approximately 20-15 minutes. It is estimated that from recruitment a participant will be involved with the study for a maximum of 24 weeks - preoperative clinics must be no more than 12 weeks prior to the surgery and the second follow-up phone call will be 12 weeks post operation. The overall timeframe for the project will be 24 months from April 2018 to April 2020, this includes ethics applications, data collection (to begin from November 2018), analysis and write up. Both arms of the trial will receive the same amount of Physiotherapy input (2 x daily visits) during their in-patient stay.

The only variable will be the issue of an Orthoglide device for the trial group to assist with completion of their knee exercises instead of a 'slider-board'. As a feasibility study no interim reports are planned however as soon as data has been analysed and reported upon it will be made available to the participants. participants will be randomised using block randomisation and data sets anonymised for analysis thus minimising researcher bias by all reasonable means for a study of this nature.

Being tested
Orthoglide, Physiotherapy only
Keywords
Knee Osteoarthritis, Orthoglide, Knee exercises, KOOS, rehabilitation
Medical subject headings
Osteoarthritis, Knee, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • OrthoglideDevice

    Knee rehabilitation device.

  • Physiotherapy onlyOther

    Also called Physiotherapy

    Physiotherapy only.

Study groups in NCT04418687
Study groupRoleWhat they receive
Physiotherapy onlyActive comparatorStandard treatment post Total Knee Arthroplasty
Receives: Other: Physiotherapy only
Physiotherapy + Orthoglide interventionExperimentalStandard treatment post TKA, with additional Orthoglide device provided.
Receives: Device: Orthoglide

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Knee Osteoarthritis Outcome Score (KOOS)

    Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms. A better score would be indicated by a higher number closer to 100.

    Measured: Change from Baseline to 6 and 12 weeks

Secondary outcomes (2)
  1. Change in Numerical Pain Rating Score (NPRS)

    Scored from 0 to 10. Higher scores (closer to 10) indicate a higher level of pain and lower numbers indicate less pain. A minimal clinically important change in NPRS is a 2 point improvement.

    Measured: Change from Baseline to 6 and 12 weeks

  2. Change in Exercise Adherence Rating Scale

    EARS consists of 6 questions scored on a 5-point Likert scale, with positively worded questions reverse scored, giving a final rating from 0 (lowest adherence) to 24 (highest adherence). Better adherence is sought with any intervention

    Measured: Change from Baseline to 6 and 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2020
  2. Study start28 Nov 2018
  3. Primary completion15 Feb 2020
  4. Study completion31 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Group 1: Physiotherapy with Orthoglide Group 2: Physiotherapy only
Masking
None (open label)
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04418687
Sponsor's protocol ID
IRAS 235931
Status last verified
Jun 2020
First submitted
15 Mar 2020
Last updated
5 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Orthoglide and Physiotherapy only in people with Knee Osteoarthritis and Physiotherapy, run by Ambreen Chohan at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Knee Osteoarthritis Outcome Score (KOOS) (time frame: Change from Baseline to 6 and 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in